en

PRODUCT DETAIL

Torisel 30 mg koncentrát a rozpúšťadlo na infúzny roztok

Code 46872
MA number EU/1/07/424/001
Product Form: cif fol 1x1,2 ml/30 mg+1x2,2 ml solv. (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EG01 Temsirolimus
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 19.11.2007
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 19.04.2022
eu-flag.png sk-flag.png